Himax's $80 Million Asset Sale: A Cash Infusion That Couldn't Stem the Bleeding

Related Articles

Is Stem, Inc. (STEM) Finally Turning the Corner with its AI-Driven Energy Solutions

5 months ago

Zentek's Capital Infusion: What Does the C$15 Million Offering Mean

4 months ago

Is Himax Technologies (HIMX) Currently Overvalued

3 months ago

Is ConocoPhillips' Permian Asset Sale a Smart Strategic Move

7 months ago

Category

You may also like

Stock News•3 weeks ago

$22 Billion in Customer Deposits Did Not Stop This Chip CEO From Selling $37 Million

Micron CEO Sanjay Mehrotra sold $37M in stock despite $22B in customer deposits, while delivering his most bullish demand statement at the Boise fab Wednesday night.

MU

Share

Stock News•1 months ago

SK hynix: The Buyback That Gets Worse As The Stock Gets Better

SK hynix sold ₩39.89 trillion of stock in July, then authorized a ₩40 trillion buyback 40 days later, with prices 0.27% apart. Shares fell ~25% by August 20, and the buyback could consume 57.6% of Q2 ...

SKHY

Share

Stock News•2 months ago

Himax Technologies, Inc. Announces Proposed Disposal of Investment in Equity-Method Investee

Himax's equity-method investee will be acquired for $80M in cash, subject to working capital adjustments. The disposal could generate a significant gain for Himax, though the exact impact depends on i...

HIMX

Share